Pre-order Enquiry
Request Free Sample
North America Topical Corticosteroids Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
SKU ID : DBMR-11617943 | Publishing Date : 01-Nov-2017 | No. of pages : 350
North America Topical Corticosteroids Market is accounted to reach USD 1,992.97 million by 2024, from USD 1,284.08 million in 2016 at a CAGR of 5.6% in the forecast period 2017 to 2024.
The major factors driving the growth of this market are chronic disease or condition, rise in aging population, growth in topical drug delivery, increasing research and development.
The key market players for North America Topical Corticosteroids Market are listed below:
• LEO Pharma
• Glaxosmithkline Plc,
• Pfizer Inc.
The market is further segmented into:
• Molecule name
• Brands
• Purchase mode
• Application
• Medication type
• Potency class
• End user
• Distribution channel
• Geography
North America topical corticosteroids market is segmented on the basis of molecule name, brands, purchase mode, application, medication type, potency class, end user, distribution channel. Based on molecule name, North America topical corticosteroids market is segmented into fludroxycortide, triamcinolone acetonide, fluocinolone acetonide, antiseptics, betamethasone, clobetasone propionate, clobetasone butyrate, halobetasone, mometasone, and others. In 2017, Fludroxycortide is expected to dominate the North America topical corticosteroids market with 26.6% market share and is expected to reach USD 579.03 million by 2024, growing at the highest CAGR of 7.0% in the forecast period 2017 to 2024.
Based on purchase mode, North America topical corticosteroids market is segmented into OTC-based and prescription-based. In 2017, prescription-based segment is expected to dominate the North America topical corticosteroids market with 72.1% market share and is expected to reach USD 1,468.23 million by 2024, growing at the highest CAGR of 6.0% in the forecast period 2017 to 2024.
Based on brands is segmented into betnovate, betnovate N, panderm plus, lobate, cosvate G, clop G, tenovate GN, lobate GM, ultiderm, flutivate, fexin, momate, candiderm, and others.
Based on application, North America topical corticosteroids market is segmented into acne, dermatitis, psoriasis, skin infection, hyperpigmentation, melasma and others. In 2017, psoriasis segment is expected to dominate the North America topical corticosteroids market with 44.8% market share and is expected to reach USD 931.52 million by 2024, growing at the highest CAGR of 6.3% in the forecast period 2017 to 2024.
North America topical corticosteroids market is segmented based on medication type into ointments, creams, liquid & solutions, lotions, gel, oils, pastes, sprays, and others. In 2017, ointments segment is expected to dominate the North America topical corticosteroids market with 33.1% market share and is expected to reach USD 639.40 million by 2024, growing at the highest CAGR of 5.2% in the forecast period 2017 to 2024. However, lotions segment is expected to grow at the highest CAGR of 6.9% in the forecast period, and is expected to reach USD 223.30 million in 2024 from USD 130.48 million in 2016.
North America topical corticosteroids market is segmented based on potency class into moderate, mild, ultra-high, and high. In 2017, moderate segment is expected to dominate the North America topical corticosteroids market with 40.2% market share and is expected to reach USD 834.43 million by 2024, growing at the highest CAGR of 6.3% in the forecast period 2017 to 2024.
North America topical corticosteroids market is segmented based on end-user into three notable segments; hospital, dermatology clinics, homecare and others. In 2017, a dermatology clinic segment is expected to dominate the North America topical corticosteroids market with 40.7% market share and is expected to reach USD 863.63 million by 2024, growing at the highest CAGR of 6.6% in the forecast period 2017 to 2024.
North America topical corticosteroids market is segmented based on distribution channel into four notable segments; hospital pharmacies, pharmacy stores, online pharmacies and others. In 2017, hospital pharmacies segment is expected to dominate the North America topical corticosteroids market with 46.3% market share and is expected to reach USD 958.63 million by 2024, growing at the highest CAGR of 6.2% in the forecast period 2017 to 2024.
Based on geography, the North America Topical Corticosteroids market is segmented into geographical regions, such as,
• U.S.,
• Canada
• Mexico
Covered in this report
The report covers the present scenario and the growth prospects of the North America Topical Corticosteroids Market for 201-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
The major factors driving the growth of this market are chronic disease or condition, rise in aging population, growth in topical drug delivery, increasing research and development.
The key market players for North America Topical Corticosteroids Market are listed below:
• LEO Pharma
• Glaxosmithkline Plc,
• Pfizer Inc.
The market is further segmented into:
• Molecule name
• Brands
• Purchase mode
• Application
• Medication type
• Potency class
• End user
• Distribution channel
• Geography
North America topical corticosteroids market is segmented on the basis of molecule name, brands, purchase mode, application, medication type, potency class, end user, distribution channel. Based on molecule name, North America topical corticosteroids market is segmented into fludroxycortide, triamcinolone acetonide, fluocinolone acetonide, antiseptics, betamethasone, clobetasone propionate, clobetasone butyrate, halobetasone, mometasone, and others. In 2017, Fludroxycortide is expected to dominate the North America topical corticosteroids market with 26.6% market share and is expected to reach USD 579.03 million by 2024, growing at the highest CAGR of 7.0% in the forecast period 2017 to 2024.
Based on purchase mode, North America topical corticosteroids market is segmented into OTC-based and prescription-based. In 2017, prescription-based segment is expected to dominate the North America topical corticosteroids market with 72.1% market share and is expected to reach USD 1,468.23 million by 2024, growing at the highest CAGR of 6.0% in the forecast period 2017 to 2024.
Based on brands is segmented into betnovate, betnovate N, panderm plus, lobate, cosvate G, clop G, tenovate GN, lobate GM, ultiderm, flutivate, fexin, momate, candiderm, and others.
Based on application, North America topical corticosteroids market is segmented into acne, dermatitis, psoriasis, skin infection, hyperpigmentation, melasma and others. In 2017, psoriasis segment is expected to dominate the North America topical corticosteroids market with 44.8% market share and is expected to reach USD 931.52 million by 2024, growing at the highest CAGR of 6.3% in the forecast period 2017 to 2024.
North America topical corticosteroids market is segmented based on medication type into ointments, creams, liquid & solutions, lotions, gel, oils, pastes, sprays, and others. In 2017, ointments segment is expected to dominate the North America topical corticosteroids market with 33.1% market share and is expected to reach USD 639.40 million by 2024, growing at the highest CAGR of 5.2% in the forecast period 2017 to 2024. However, lotions segment is expected to grow at the highest CAGR of 6.9% in the forecast period, and is expected to reach USD 223.30 million in 2024 from USD 130.48 million in 2016.
North America topical corticosteroids market is segmented based on potency class into moderate, mild, ultra-high, and high. In 2017, moderate segment is expected to dominate the North America topical corticosteroids market with 40.2% market share and is expected to reach USD 834.43 million by 2024, growing at the highest CAGR of 6.3% in the forecast period 2017 to 2024.
North America topical corticosteroids market is segmented based on end-user into three notable segments; hospital, dermatology clinics, homecare and others. In 2017, a dermatology clinic segment is expected to dominate the North America topical corticosteroids market with 40.7% market share and is expected to reach USD 863.63 million by 2024, growing at the highest CAGR of 6.6% in the forecast period 2017 to 2024.
North America topical corticosteroids market is segmented based on distribution channel into four notable segments; hospital pharmacies, pharmacy stores, online pharmacies and others. In 2017, hospital pharmacies segment is expected to dominate the North America topical corticosteroids market with 46.3% market share and is expected to reach USD 958.63 million by 2024, growing at the highest CAGR of 6.2% in the forecast period 2017 to 2024.
Based on geography, the North America Topical Corticosteroids market is segmented into geographical regions, such as,
• U.S.,
• Canada
• Mexico
Covered in this report
The report covers the present scenario and the growth prospects of the North America Topical Corticosteroids Market for 201-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
